Therapeutic Targets Database
BIDD Pharmainformatics Databases
 
   
   

 

TTD Drug ID: DAP000567

Drug Information
NameFludarabine
SynonymsD07966; SQ Fludarabine; C10H12FN5O4; Fludarabinum; Fludarabina [Spanish]; NSC 118218; F-Ara-A; CCRIS 3382; AC1Q51CF; 9H-Purin-6-amine, 9-beta-D-arabinofuranosyl-2-fluoro-; FT-0082766; 9-beta-D-arabinofuranosyl-2-fluoro-9H-purin-6-amine; UNII-P2K93U8740; UNII-1X9VK9O1SC; FaraA; NSC 118218H; Fludara, Fludarabine; SAM002548956; (2R,3S,4S,5R)-2-(6-amino-2-fluoropurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol; MLS000028687; 2-Fluoro Ara-A; (2R,3S,4S,5R)-2-(6-amino-2-fluoro-9H-purin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol; Fludarabina; Fluradosa (TN); CHEMBL1568; NSC-118218; CID657237; HSDB 6964; 21679-14-1; AC1LCW8I; Fludarabine; ZINC04216238; S1491_Selleck; EINECS 244-525-5; LS-15061; 9H-Purin-6-amine, 9-beta-D-arabinofuranosyl-2-fluoro- (9CI); Adenine, 9-beta-D-arabinofuranosyl-2-fluoro-; I14-4978; Fludarabine [INN]; 2-F-ara-A; Fludarabine (INN); Fludarabinum [Latin]; SMR000058874; CPD000058874; 9-beta-D-Arabinofuranosyl-2-fluoroadenine; Fluradosa; 2-Fluoro-9-beta-D-arabinofuranosyladenine
IndicationHematological malignancies
[ICD9: 200-209   ICD10: C81-C96]
Approved    [1]
Structure

Click to save drug structure in 3D MOL format

Click to save drug structure in 2D MOL format
InChI1S/C10H12FN5O4/c11-10-14-7(12)4-8(15-10)16(2-13-4)9-6(19)5(18)3(1
-17)20-9/h2-3,5-6,9,17-19H,1H2,(H2,12,14,15)/t3-,5-,6+,9-/m1/s1
InChIKeyHBUBKKRHXORPQB-FJFJXFQQSA-N
Canonical SMILESC1=NC2=C(N1C3C(C(C(O3)CO)O)O)N=C(N=C2N)F    
Isomeric SMILESC1=NC2=C(N1[C@H]3[C@H]([C@@H]([C@H](O3)CO)O)O)N=C(N=C2N)F
Therapeutic ClassAntineoplastic Agents
CAS NumberCAS 75607-67-9
FormulaC10H13FN5O7P
PubChem Compound IDCID 657237.
PubChem Substance IDSID 172834.
SuperDrug ATC IDL01BB05
SuperDrug CAS ID021679141;
TargetAdenosine deaminaseInhibitor[2]
Ref 1Natural products as sources of new drugs over the last 25 years. J Nat Prod. 2007 Mar;70(3):461-77. Epub 2007 Feb 20. To Reference
Ref 2Purine nucleoside analogs in indolent non-Hodgkin's lymphoma. Oncology (Williston Park). 2000 Jun;14(6 Suppl 2):13-5. To Reference



 

Welcome to sign our Guestbook.

If you find any error in data or bug in web service, please kindly report it to Dr. Zhu.


Dr. Chen Yuzong
Deputy Director of Center for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore


All rights reserved.

   
 
 
Computer-aided Drug Design
about BIDD |  databases |  software |  teaching |  research |  links

 

Department of Computational Science | National University of Singapore | Blk S17, 3 Science Drive 2, Singapore 117543